PET Clinics Lung Cancer Preface: Lung Cancer Staging of Non-Small-Cell Lung Cancer Lung Neoplasms with Low F18-Fluorodeoxyglucose Avidity 18F-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease Genomic Characterization of Lung Cancer and Its Impact on the Use and Timing of PET in Therapeutic Response Assessment Treatment Planning for Radiation Therapy Prognostic Value of 18F-Fluorodeoxyglucose PET/Computed Tomography in Non-Small-Cell Lung Cancer Non-Small-Cell Lung Cancer PET Imaging Beyond F18 Fluorodeoxyglucose Future Directions in PET Imaging of Lung Cancer Improved Detection of Small Pulmonary Nodules Through Simultaneous MR/PET Imaging Practical Considerations for Clinical PET/MR Imaging Diagnostic Imaging and Newer Modalities for Thoracic Diseases: PET/Computed Tomographic Imaging and Endobronchial Ultrasound for Staging and Its Implication for Lung Cancer.